成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 1092351-67-1 Chemical Structure| 1092351-67-1

Structure of Torkinib
CAS No.: 1092351-67-1

Chemical Structure| 1092351-67-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 1092351-67-1

,{[proInfo.pro_purity]}

Torkinib (PP 242) is a selective and ATP-competitive mTOR inhibitor with an IC50 of 8 nM, inhibiting both mTORC1 and mTORC2 with IC50 values of 30 nM and 58 nM, respectively.

Synonyms: PP242

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Torkinib

CAS No. :1092351-67-1
Formula : C16H16N6O
M.W : 308.34
SMILES Code : NC1=C2C(N(N=C2C3=CC4=C(N3)C=CC(O)=C4)C(C)C)=NC=N1
Synonyms :
PP242
MDL No. :MFCD12196869
InChI Key :MFAQYJIYDMLAIM-UHFFFAOYSA-N
Pubchem ID :135565635

Safety of Torkinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Torkinib

PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • mTOR

    mTOR, IC50:8 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
iPSC-derived neurons 10 μM 24 h or 48 h Torkinib treatment significantly reduced cytoplasmic FUS-eGFP levels compared to controls and restored homeostasis of ALS-associated RBPs as well as p62 in iPSC-derived neurons PMC6570784
pancreatic acinar cells 50 nM Investigated the effect of Torkinib on pancreatic acinar cells, finding that it inhibits the activation of EGFR and MEK, thereby affecting the phosphorylation and nuclear translocation of HSF1. PMC7797143
4T1 cells 2.5 μM 24 h Inhibited RAC1Q61L-mediated SREBF transcriptional activity PMC11705731

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
African clawed frog (Xenopus laevis) Embryos Aqueous solution 12.5 nmol/mL 6 hours Torkinib treatment eliminated the metabolic difference between diploids and triploids, indicating that energy expenditure related to the mTOR pathway is associated with cell size PMC10184464

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.24mL

0.65mL

0.32mL

16.22mL

3.24mL

1.62mL

32.43mL

6.49mL

3.24mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories